CCDC54
gene geneOn this page
Also known as NYD-SP17FLJ25362SP17
Summary
CCDC54 (coiled-coil domain containing 54, HGNC:30703) is a protein-coding gene on chromosome 3q13.12, encoding Coiled-coil domain-containing protein 54 (Q8NEL0).
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 51 total
- MANE Select transcript:
NM_032600
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30703 |
| Approved symbol | CCDC54 |
| Name | coiled-coil domain containing 54 |
| Location | 3q13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | NYD-SP17, FLJ25362, SP17 |
| Ensembl gene | ENSG00000138483 |
| Ensembl biotype | protein_coding |
| Entrez | 84692 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000261058
RefSeq mRNA: 1 — MANE Select: NM_032600
NM_032600
CCDS: CCDS2949
Canonical transcript exons
ENST00000261058 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000934129 | 107377439 | 107378635 |
Expression profiles
Bgee: expression breadth broad, 98 present calls, max score 98.60.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1163 / max 113.6002, expressed in 3 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 37781 | 0.0616 | 3 |
| 37782 | 0.0547 | 3 |
Top tissues by expression
219 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 98.60 | gold quality |
| left testis | UBERON:0004533 | 97.44 | gold quality |
| right testis | UBERON:0004534 | 97.27 | gold quality |
| testis | UBERON:0000473 | 94.40 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 92.56 | gold quality |
| adult organism | UBERON:0007023 | 83.95 | gold quality |
| tibialis anterior | UBERON:0001385 | 63.60 | silver quality |
| ileal mucosa | UBERON:0000331 | 59.73 | silver quality |
| stromal cell of endometrium | CL:0002255 | 55.19 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| deltoid | UBERON:0001476 | 53.78 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 53.07 | gold quality |
| heart left ventricle | UBERON:0002084 | 51.59 | gold quality |
| cardiac ventricle | UBERON:0002082 | 51.20 | gold quality |
| myocardium | UBERON:0002349 | 50.25 | gold quality |
| corpus callosum | UBERON:0002336 | 48.98 | silver quality |
| apex of heart | UBERON:0002098 | 47.79 | gold quality |
| placenta | UBERON:0001987 | 47.34 | gold quality |
| quadriceps femoris | UBERON:0001377 | 47.29 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 47.03 | gold quality |
| pancreatic ductal cell | CL:0002079 | 46.97 | silver quality |
| lower esophagus mucosa | UBERON:0035834 | 46.09 | silver quality |
| heart | UBERON:0000948 | 45.53 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 45.52 | gold quality |
| vastus lateralis | UBERON:0001379 | 45.40 | gold quality |
| left ovary | UBERON:0002119 | 44.78 | gold quality |
| adrenal tissue | UBERON:0018303 | 44.60 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.80 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- data supporting the rationale for further investigations of Sp17 for tumor vaccines in testicular cancer. (review) (PMID:16138340)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Ccdc54 | ENSMUSG00000050685 |
| rattus_norvegicus | Ccdc54 | ENSRNOG00000028005 |
Protein
Protein identifiers
Coiled-coil domain-containing protein 54 — Q8NEL0 (reviewed: Q8NEL0)
Alternative names: Testis development protein NYD-SP17
All UniProt accessions (2): A0A140VJF9, Q8NEL0
RefSeq proteins (1): NP_115989* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR037758 | CCDC54 | Family |
UniProt features (4 total): chain 1, coiled-coil region 1, modified residue 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NEL0-F1 | 59.69 | 0.20 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 182
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 26 (showing top):
TGACATY_UNKNOWN, YKACATTT_UNKNOWN, MARTENS_TRETINOIN_RESPONSE_DN, GSE14026_TH1_VS_TH17_DN, GSE14308_TH1_VS_NAIVE_CD4_TCELL_DN, chr3q13, GSE27786_ERYTHROBLAST_VS_MONO_MAC_UP, GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_UP, GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_UP, GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP, GSE1566_WT_VS_EZH2_KO_LN_TCELL_UP, GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_UP, GSE2585_CTEC_VS_THYMIC_DC_UP, ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP, GSE4590_PRE_BCELL_VS_SMALL_PRE_BCELL_DN
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
354 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CCDC54 | C22orf23 | Q9BZE7 | 592 |
| CCDC54 | CCDC187 | A0A096LP49 | 543 |
| CCDC54 | TMCO2 | Q7Z6W1 | 543 |
| CCDC54 | ADAM29 | Q9UKF5 | 537 |
| CCDC54 | GARIN1B | Q96KD3 | 515 |
| CCDC54 | RIMBP3 | Q9UFD9 | 513 |
| CCDC54 | CXorf65 | A6NEN9 | 507 |
| CCDC54 | C20orf173 | Q96LM9 | 507 |
| CCDC54 | FAM209A | Q5JX71 | 503 |
| CCDC54 | SOX30 | O94993 | 485 |
| CCDC54 | TNP1 | P09430 | 484 |
| CCDC54 | FAM81B | Q96LP2 | 484 |
| CCDC54 | ZC3H11D | Q8NA57 | 480 |
| CCDC54 | CIMIP4 | O43247 | 476 |
| CCDC54 | BBX | Q8WY36 | 471 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CCDC54 | RSL1D1 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (2): CCDC54 (Proximity Label-MS), CCDC54 (Negative Genetic)
ESM2 similar proteins: A0A023PXJ3, A1STV0, A5HBD7, A6NC05, A6X970, A8Y985, C1P605, F5HA06, O06472, O94339, P03080, P03081, P03083, P04009, P0C306, P0C307, P0DOI8, P0DOI9, P0DOJ0, P21071, P21972, P24598, P24756, P24852, P39551, Q01009, Q01031, Q03418, Q04406, Q07509, Q09264, Q0V9U8, Q11177, Q32759, Q3E8K6, Q4R363, Q5T3Y7, Q5UPF3, Q66H70, Q6ENI8
Diamond homologs: Q29RU3, Q4R363, Q8NEL0, Q9DAL3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
51 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 50 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
191 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:107377990:GCAT:G | donor_gain | 0.6600 |
| 3:107378065:G:GT | donor_gain | 0.6000 |
| 3:107378181:GCCC:G | donor_gain | 0.5700 |
| 3:107378358:A:T | donor_gain | 0.5500 |
| 3:107377973:T:TA | acceptor_gain | 0.5400 |
| 3:107378018:A:T | donor_gain | 0.5400 |
| 3:107378187:T:G | donor_gain | 0.5200 |
| 3:107378072:GGG:G | donor_gain | 0.5000 |
| 3:107378073:GGG:G | donor_gain | 0.5000 |
| 3:107378152:G:GT | donor_gain | 0.5000 |
| 3:107378176:A:T | donor_gain | 0.4900 |
| 3:107378153:A:T | donor_gain | 0.4800 |
| 3:107377991:C:T | donor_gain | 0.4700 |
| 3:107378259:C:G | donor_gain | 0.4700 |
| 3:107378354:G:GT | donor_gain | 0.4700 |
| 3:107377866:A:AG | acceptor_gain | 0.4500 |
| 3:107377867:G:GG | acceptor_gain | 0.4500 |
| 3:107378291:C:T | donor_gain | 0.4500 |
| 3:107378258:A:AG | donor_gain | 0.4400 |
| 3:107378076:TA:T | donor_gain | 0.4200 |
| 3:107378077:AA:A | donor_gain | 0.4200 |
| 3:107378078:AA:A | donor_gain | 0.4200 |
| 3:107378254:C:G | donor_gain | 0.4200 |
| 3:107378357:G:GT | donor_gain | 0.4200 |
| 3:107378338:C:G | donor_gain | 0.4100 |
| 3:107378389:T:G | donor_gain | 0.4100 |
| 3:107378175:G:GT | donor_gain | 0.4000 |
| 3:107378250:GAAAC:G | donor_gain | 0.4000 |
| 3:107377865:AAGTC:A | acceptor_gain | 0.3900 |
| 3:107377866:AGTC:A | acceptor_gain | 0.3900 |
AlphaMissense
2185 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:107378329:T:A | W248R | 0.947 |
| 3:107378329:T:C | W248R | 0.947 |
| 3:107378344:T:C | F253L | 0.914 |
| 3:107378346:T:A | F253L | 0.914 |
| 3:107378346:T:G | F253L | 0.914 |
| 3:107378398:T:C | F271L | 0.887 |
| 3:107378400:C:A | F271L | 0.887 |
| 3:107378400:C:G | F271L | 0.887 |
| 3:107378362:T:A | W259R | 0.879 |
| 3:107378362:T:C | W259R | 0.879 |
| 3:107378339:T:C | L251P | 0.863 |
| 3:107378368:T:C | F261L | 0.863 |
| 3:107378370:T:A | F261L | 0.863 |
| 3:107378370:T:G | F261L | 0.863 |
| 3:107377826:T:C | L80P | 0.860 |
| 3:107378411:T:C | L275P | 0.860 |
| 3:107378371:T:C | F262L | 0.838 |
| 3:107378373:C:A | F262L | 0.838 |
| 3:107378373:C:G | F262L | 0.838 |
| 3:107378364:G:C | W259C | 0.834 |
| 3:107378364:G:T | W259C | 0.834 |
| 3:107378506:T:C | C307R | 0.834 |
| 3:107378407:T:A | W274R | 0.826 |
| 3:107378407:T:C | W274R | 0.826 |
| 3:107378331:G:C | W248C | 0.818 |
| 3:107378331:G:T | W248C | 0.818 |
| 3:107378339:T:A | L251Q | 0.786 |
| 3:107378319:C:A | D244E | 0.778 |
| 3:107378319:C:G | D244E | 0.778 |
| 3:107378337:G:C | K250N | 0.778 |
dbSNP variants (sampled 300 via entrez): RS1001944039 (3:107378858 A>T), RS1002985467 (3:107375872 A>G), RS1004668893 (3:107377330 A>C), RS1006173824 (3:107375481 T>G), RS1006341931 (3:107378689 A>C,G), RS1007578771 (3:107375474 T>C), RS1007807388 (3:107376317 CAA>C,CA), RS1007896540 (3:107378638 T>C), RS1008852169 (3:107376956 A>G,T), RS1009022536 (3:107377811 C>G,T), RS1009317573 (3:107377263 G>A), RS1011983071 (3:107377621 G>A,T), RS1013411055 (3:107376229 G>A,C), RS1014812146 (3:107375863 C>G), RS1016892766 (3:107377382 T>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008170_7 | Thyroglobulin plasma levels | 4.000000e-06 |
| GCST009391_1522 | Metabolite levels | 5.000000e-06 |
| GCST009391_368 | Metabolite levels | 7.000000e-06 |
| GCST010796_118 | Electrocardiogram morphology (amplitude at temporal datapoints) | 3.000000e-08 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0010050 | thyroglobulin measurement |
| EFO:0010418 | triacylglycerol 52:6 measurement |
| EFO:0010435 | triacylglycerol 56:8 measurement |
| EFO:0004327 | electrocardiography |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| hydroxyhydroquinone | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Valproic Acid | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.